Business
Ocumetics announces listing on the OTC QB Market
(TheNewswire) Calgary, Alberta - TheNewswire - September 12, 2022 - Ocume...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics announces listing on the OTC QB Market \n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Calgary, Alberta -\n \n \n TheNewswire -\n \n \n September 12, 2022 -\n \n \n Ocumetics Technology\nCorp.\n \n \n (“\n \n \n Ocumetics\n \n \n ” or the “\n \n \n Company\n \n \n ”)\n(\n \n \n TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) is pleased to\nannounce that its common shares have commenced trading on the OTC QB\nMarket under the symbol \"OTCFF\". The Company's common shares\nwill continue to trade on the TSX Venture Exchange under the symbol\n“OTC” and the Frankfurt Stock Exchange under the symbol\n“2QBO”.\n \n \n \n \n The Company has listed on the OTC QB Market to\nfacilitate greater trading visibility and convenience for US-based\ninvestors, resulting in more liquidity and greater reach.\n \n \n \n \n “The rapid development of our adaptive intraocular\nlens technology has caused many US investors to ask us to obtain a US\nlisting to allow them to purchase Ocumetics stock,” says Dr. Mark\nLee, CEO of Ocumetics.\n \n \n \n \n “We are pleased to complete this listing and look\nforward to increasing our base of US investors and sharing development\nprogress of our accommodating intraocular lens with this group,”\nadds Dr. Lee.\n \n \n \n \n About Ocumetics\n \n \n \n \n Ocumetics Technology Corp.\n \n \n (\n \n \n TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO)\nis a Canadian research and product development company that\nspecializes in adaptive lens designs.  Ocumetics is in the\npreclinical study stage of a game-changing technology for the\nophthalmic industry.  Ocumetics has developed an expandable\nintraocular lens that fits within the natural lens compartment of the\neye potentially to eliminate the need for corrective lenses.  It is\ndesigned to allow the eye’s natural muscle activity to shift focus\nfrom distance to near.\n \n \n \n \n FOR FURTHER INFORMATION, PLEASE\nCONTACT:\n \n \n \n \n Dr. Mark Lee\n \n \n \n \n President and CEO\n \n \n \n \n (604) 832-6052\n \n \n \n \n Neither the TSX\nVenture Exchange nor its Regulation Services Provider (as that term is\ndefined in the policies of the TSX Venture Exchange) accepts\nresponsibility for the adequacy or accuracy of this release.\n \n \n \n Copyr...